Pre-operative Immunotherapy Combination Strategies in Breast Cancer (ECLIPSE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03395899 |
|
Recruitment Status :
Recruiting
First Posted : January 10, 2018
Last Update Posted : January 10, 2018
|
Sponsor:
Queen Mary University of London
Collaborators:
Kliniken Essen-Mitte
MedSIR
Asan Medical Center
Hoffmann-La Roche
Information provided by (Responsible Party):
Queen Mary University of London
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 30, 2018 |
| Estimated Study Completion Date : | November 30, 2020 |